Sanofi (SNY) Net Margin (2009 - 2026)

Sanofi has disclosed Net Margin across 18 years of filings, most recently posting 2.96% for Q2 2026.

• In Q2 2026, Net Margin fell 3647.0% year-over-year to 2.96%; the TTM figure through Jun 2026 stood at 8.7% (down 1527.0% YoY), while the FY2025 annual figure was 17.91%, up 437.0% from the prior year.
• Net Margin came in at 2.96% for Q2 2026 at Sanofi, down from 15.36% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 77.02% in Q4 2025 to a low of 9.8% in Q4 2023.
• Average Net Margin over 5 years is 19.11%, with a median of 16.0% recorded in 2022.
• Year-over-year, Net Margin soared 6927 bps in 2025 and slumped 3647 bps in 2026.
• Over 5 years, Net Margin stood at 13.97% in 2022, then tumbled by 170 bps to 9.8% in 2023, then surged by 179 bps to 7.76% in 2024, then jumped by 893 bps to 77.02% in 2025, then plunged by 96 bps to 2.96% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 2.96% in Q2 2026, 15.36% in Q1 2026, and 77.02% in Q4 2025.